Imaging evaluation of COVID-19 in the emergency department.


Journal

Emergency radiology
ISSN: 1438-1435
Titre abrégé: Emerg Radiol
Pays: United States
ID NLM: 9431227

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 06 04 2020
accepted: 04 05 2020
pubmed: 26 5 2020
medline: 1 12 2020
entrez: 26 5 2020
Statut: ppublish

Résumé

The purpose of this study is to elucidate the chest imaging findings of suspected COVID-19 patients presenting to the emergency department and the relationship with their demographics and RT-PCR testing results. Patients presenting to the ED between March 12 and March 28, 2020, with symptoms suspicious for COVID-19 and subsequent CXR and/or CT exam were selected. Patients imaged for other reasons with findings suspicious for COVID-19 were also included. Demographics, laboratory test results, and history were extracted from the medical record. Descriptive statistics were used to explore the relationship between imaging and these factors. A total of 227 patients from the emergency department were analyzed (224 CXRs and 25 CTs). Of the 192 patients with COVID-19 results, 173 (90.1%) had COVID-19 RT-PCR (+). Abnormal imaging (CXR, 85.7% and/or CT, 100%) was noted in 155 (89.6%) of COVID-19 RT-PCR (+) cases. The most common imaging findings were mixed airspace/interstitial opacities (39.8%) on CXR and peripheral GGOs on CT (92%). The most common demographic were African Americans (76.8%). Furthermore, 97.1% of African Americans were RT-PCR (+) compared to 65.8% of Caucasians. We found a similar spectrum of thoracic imaging findings in COVID-19 patients as previous studies. The most common demographic were African Americans (76.8%). Furthermore, 97.1% of African Americans were RT-PCR (+) compared to 65.8% of Caucasians. Both CT and CXR can accurately identify COVID-19 pneumonitis in 89.6% of RT-PCR (+) cases, 89.5% of false negatives, and 72.7% of cases with no RT-PCR result.

Identifiants

pubmed: 32449099
doi: 10.1007/s10140-020-01787-0
pii: 10.1007/s10140-020-01787-0
pmc: PMC7246086
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

579-588

Références

Radiology. 2020 Apr;295(1):202-207
pubmed: 32017661
Radiology. 2020 Aug;296(2):E72-E78
pubmed: 32216717
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Radiology. 2020 Jun;295(3):200463
pubmed: 32077789
Eur Radiol. 2020 Aug;30(8):4381-4389
pubmed: 32193638
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Clin Imaging. 2020 Jul;63:7-9
pubmed: 32120312
Eur J Radiol. 2020 May;126:108941
pubmed: 32193037
Radiology. 2020 Aug;296(2):E41-E45
pubmed: 32049601
J Comput Assist Tomogr. 2020 May/Jun;44(3):311-313
pubmed: 32217900
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353
Eur Radiol. 2020 Jun;30(6):3306-3309
pubmed: 32055945

Auteurs

Amir Pakray (A)

Department of Radiology and Molecular Imaging, Beaumont Health, 3601 W. 13 Mile Road, Royal Oak, MI, 48073, USA. Amir.Pakray@beaumont.org.

David Walker (D)

Department of Radiology and Molecular Imaging, Beaumont Health, 3601 W. 13 Mile Road, Royal Oak, MI, 48073, USA.

Alexander Figacz (A)

Department of Radiology and Molecular Imaging, Beaumont Health, 3601 W. 13 Mile Road, Royal Oak, MI, 48073, USA.

Stephen Kilanowski (S)

Department of Radiology and Molecular Imaging, Beaumont Health, 3601 W. 13 Mile Road, Royal Oak, MI, 48073, USA.

Casey Rhodes (C)

Department of Radiology and Molecular Imaging, Beaumont Health, 3601 W. 13 Mile Road, Royal Oak, MI, 48073, USA.

Shashin Doshi (S)

Department of Radiology and Molecular Imaging, Beaumont Health, 3601 W. 13 Mile Road, Royal Oak, MI, 48073, USA.

Mary Coffey (M)

Department of Radiology and Molecular Imaging, Beaumont Health, 3601 W. 13 Mile Road, Royal Oak, MI, 48073, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH